Welcome
International Conference of Drug Regulatory Authorities
(icdra)
Since
it was founded in 1980, the International Conference of Drug
Regulatory Authorities (icdra) has brought together regulatory
authorities from WHO Member States to strengthen collaboration and
develop international consensus on regulatory priorities. icdra
provides a unique forum to support and guide regulatory
authorities, WHO and international stakeholders in confronting the
challenges and highlighting the opportunities of today’s dynamic
and innovative regulatory sector.
Delegates from
regulatory authorities around the world will participate in an
event programme designed to evoke ideas and discussion on the
current key priorities in the regulatory environment while also
ensuring valuable engagement with leading stakeholders across
industry, research as well as healthcare professionals in the open
pre-icdra conference.
The 19th icdra will facilitate focused discussions on
quality issues, regulatory reforms and strengthening regulatory
systems, safety of medical products, detection, prevention and
response to substandard and falsified medical products, access to
quality medical products, smart regulation of clinical trials,
regulatory collaboration, harmonization, rationalization and
reliance, access to new and novel technologies, regulation of
novel medical products, regulation of herbal medicines, etc.
The theme of the conference is Smart Regulation: Delivering
Quality Assured Medical Products for All.